Breaking News

Clinical Correlations voted Best Clinical Sciences Weblog of 2008

January 23, 2009
Clinical Correlations voted Best Clinical Sciences Weblog of 2008

We are proud to announce that Clinical Correlations has been voted the Best Clinical Sciences Weblog  of 2008 in Medgadget’s 5th annual Medical Weblog Awards.  First, we’d like to congratulate all the other nominees and winners. It’s exciting to see such incredible content throughout the medical blogosphere and to share this recognition with so many others who clearly display a passion for medicine. We’d also like to sincerely thank all of our readers, writers and editors for their continued support and for making this award possible.

 

-the Clinical Correlations Editorial Board

Read more »

Breaking News: FDA Advisory Committee Calls For Ban on Long Acting Beta Agonists in Asthma

December 12, 2008
Breaking News: FDA Advisory Committee Calls For Ban on Long Acting Beta Agonists in Asthma

Commentary by Denise Pate MD, PGY-1 

The FDA released a 460 page document regarding the safety of long acting beta agonists (LABA) for the use of asthma, in addition to a two day advisory committee meeting this week on the call to ban LABA when used alone and not in combination with an inhaled steroid. The FDA found through a meta-analysis of 110 trials studying 4 drugs—2 LABAs, Foradil and Serevent, and 2 LABA/ICS (Inhaled Corticosteroids) Advair and Symbicort. The study found that there was…

Read more »

Celebrating our second anniversary!!

December 4, 2008
Celebrating our second anniversary!!

Commentary by Neil Shapiro MD, Editor-in-Chief, Clinical Correlations 

Two years, four hundred posts…wow, I’ve finally even impressed myself. It’s hard to believe that we’re here celebrating our second anniversary, although there are times when I feel like we’ve been working on this forever. It’s been a tremendous ride and fortunately I think over these two years we have gained some traction and some real momentum.

I’ve frequently been accused of not being more patient with the evolution of Clinical Correlations. In some of my colleague’s eyes, I’m…

Read more »

Clinical Correlations’ Editor-in-Chief Named a Top Hospitalist

November 13, 2008
Clinical Correlations’ Editor-in-Chief Named a Top Hospitalist

Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations

We are proud to announce that our editor-in-chief, Neil Shapiro MD, has been selected by ACP Hospitalist as a Top Hospitalist for his work to establish and maintain Clinical Correlations and is currently featured in the ACP Hospitalist magazine. Neil was chosen as one out of only ten physicians who were selected for “making notable contributions to the field.” As the article states, the main goal of Clinical Correlations has always been to foster interest and excitement in internal medicine.  Having worked…

Read more »

Breaking News: The Jupiter Trial

November 12, 2008
Breaking News: The Jupiter Trial

Commentary by Ilana Bragin MD, PGY-3

This week online in the NEJM, the results of a trial known as Jupiter were presented in an article that will likely change the way we approach cardiovascular health protection. The Jupiter trial attempts to answer this perturbing question: “Why do half of all myocardial infarctions and strokes occur in apparently healthy men and women with levels of LDL that are below currently recommended thresholds of treatment?” The study addresses the biomarker C-reactive protein, an inflammatory marker that has long been…

Read more »

Breaking News: USPSTF Recommends Against Routine Screening for Colorectal Cancer After Age 75

October 8, 2008

Commentary by Andrew McKinstry MD, PGY-1 (reviewed by Michael Poles, MD, Associate Editor Clinical Correlations, Assistant Professor of Medicine, Section of Gastroenterology)

Hot on the heels of its recommendation in August against routine screening for prostate cancer in men over 75, the US Preventive Services Task Force has issued recommendations against routine screening for colorectal cancer in patients over the age of 75- Yes, you read that correctly, NO routine screening for colorectal cancer past age 75.  In a report updating their recommendations from 2002, the…

Read more »

Breaking News: Revenge of the Gila Monster?

August 20, 2008
Breaking News: Revenge of the Gila Monster?

Commentary by Rachana Jani MD, PGY-2

As recently reported in ShortCuts, Byetta recently made headlines after the suggestion of a mortality benefit for patients taking the drug in a small subset of the Accord study.  So is this the new golden drug for diabetics? Perhaps not. This week, the FDA updated a previous alert warning providers about the risks of pancreatitis in patients taking Byetta. Last October, the FDA first issued an alert after there had been 30 postmarketing reports of acute pancreatitis in patients who had recently been started on Byetta. Though…

Read more »

Breaking News: USPSTF Issues New Prostate Cancer Screening Guidelines

August 5, 2008

Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations

The US Preventive Services Task Force issued new guidelines for prostate cancer screening on Monday.  For the first time, the task force recommends AGAINST routine screening in patients over 75 years of age, citing the “moderate to substantial” harms over small to no benefits from screening. The task force reports that there continues to be inadequate evidence that the PSA improves healthcare outcomes at any age.  However, even if there is eventual evidence that screening is beneficial in younger patients, because men over…

Read more »

New National Network E-mails Drug Alerts Instantly to U.S. Doctors

July 31, 2008
New National Network E-mails Drug Alerts Instantly to U.S. Doctors

Commentary by Marilena S. Antonopoulos Pharm.D, Pharmacology Section Editor

Until recently, drugs safety alerts (aka “Dear Doctor letters”) were sent out to physicians through traditional U.S. mail, a slow and error-prone process. These alerts can be significantly delayed and may not even reach the intended recipient. In an effort to improve the speed and efficacy of the delivery of FDA mandated patient safety alerts to physicians and other healthcare providers, the Health Care Notification Network (HCNN) has announced the launching of its online service that…

Read more »

Breaking news: FDA issues new Boxed Warning for Fluoroquinolones

July 10, 2008
Breaking news: FDA issues new Boxed Warning for Fluoroquinolones

Commentary by Marilena S. Antonopoulos, PharmD, Pharmacology Editor

On July 8th, the FDA notified the manufacturers of fluoroquinolone antimicrobial drugs that a Boxed Warning in the product labeling and a Medication Guide for patients concerning the increased risk of tendinitis and tendon rupture is necessary. The FDA conducted a new analysis of the available literature and post-marketing adverse event reports which reconfirms that the use of fluoroquinolones is associated with an increased risk of tendon rupture.

The risk of developing fluoroquinolone-associated tendinitis and tendon rupture…

Read more »

Welcome to Clinical Correlations 2.0

July 1, 2008
Welcome to Clinical Correlations 2.0

317 posts, 67,000 unique visitors from 167 different countries and almost 100,000 hits later and we’re still here. It’s time we evolved…

Welcome to Clinical Correlations Version 2.0. What better day than July 1st, the start of the academic year to celebrate our success with a total redesign of our site. Our new tagline says it all: “A Daily Dose of Medicine.” We are looking to be your destination on the internet to receive a morsel of internal medicine wisdom every day.

Click around and…

Read more »

Some say tomato, some say nationwide outbreak of Samonellosis

June 10, 2008
Some say tomato, some say nationwide outbreak of Samonellosis

Commentary by Chirayu Gor, MD

The CDC has issued an alert regarding the outbreak of a rare type of Salmonella, termed Salmonella Saintpaul. Since mid-April, over 140 persons have been identified in 16 states with this uncommon serotype of Salmonella. Preliminary investigation has implicated tomatoes.

Read more »